ENDRA Life Sciences (NDRA) Change in Accured Expenses: 2016-2021
Historic Change in Accured Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$37,693.
- ENDRA Life Sciences' Change in Accured Expenses rose 90.36% to -$37,693 in Q4 2021 from the same period last year, while for Dec 2021 it was $491,104, marking a year-over-year increase of 158.82%. This contributed to the annual value of -$198,867 for FY2024, which is 75.81% up from last year.
- As of Q4 2021, ENDRA Life Sciences' Change in Accured Expenses stood at -$37,693, which was up 42.66% from -$65,736 recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Change in Accured Expenses registered a high of $818,065 during Q2 2021, and its lowest value of -$390,823 during Q4 2020.
- Its 3-year average for Change in Accured Expenses is $34,688, with a median of -$102,542 in 2019.
- Examining YoY changes over the last 5 years, ENDRA Life Sciences' Change in Accured Expenses showed a top increase of 665.83% in 2019 and a maximum decrease of 1,263.08% in 2019.
- Over the past 5 years, ENDRA Life Sciences' Change in Accured Expenses (Quarterly) stood at $536,173 in 2017, then plummeted by 117.49% to -$93,756 in 2018, then skyrocketed by 665.83% to $530,503 in 2019, then plummeted by 173.67% to -$390,823 in 2020, then spiked by 90.36% to -$37,693 in 2021.
- Its Change in Accured Expenses was -$37,693 in Q4 2021, compared to -$65,736 in Q3 2021 and $818,065 in Q2 2021.